+91- 99099 19545
info@accuprec.com
Zydus Cadila has received the final approval from the USFDA to market Valsartan and Hydrochlorothiazide Tablets USP (US RLD – Diovan HCT Tablets) in the strengths of 80 mg/12.5 mg, 160 mg/12.5 mg, 160 mg/25 mg, 320 mg/12.5 mg, and...
Read More
Statement by FDA Commissioner Scott Gottlieb, M.D., on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development: Modernizing clinical trials is an agency wide priority. As more diseases are being redefined based...
Read More
"Innovation is the power which can bring prosperity progress." This was stated by Dr Ketan Patel, Chairman & Managing Director of troikaa pharmaceuticals, who is recently appointed as Chairman of BoG at NIPER-Ahmedabad. Dr Patel was speaking at GTU Multidisciplinary...
Read More
Ahmedabad Textile Industry's Research Association [ATIRA] organized a Training Program on 'Implementation of ISO/IEC 17025:2017 and Internal Audit'. The training programme was organised from 11th March to 14th March at ATIRA campus near AMA, Ahmedabad. Dr. Rina Gokani, Director &...
Read More
‘Enterprising Giants’, an event by TiE Ahmedabad, was organised on March 14, 2019 at Novotel. It invited home-grown successful entrepreneurs to share experiences on building value, staying ahead, and surviving tough times. Arjun Handa, Vice Chairman & MD of Claris,...
Read More
The U.S. Food and Drug Administration today posted a warning letter to Nutra Pharma Corp. for illegally marketing unapproved products labeled as homeopathic with claims about their ability to treat addiction and chronic pain, including pain associated with cancer, diabetes,...
Read More
Zydus Cadila has received the final approval from the USFDA to market Acyclovir Ointment USP (US RLD – Zovirax®), 5%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. Acyclovir is an antiviral drug which stops the...
Read More
Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon's commitment to...
Read More
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today the appointment of Mamata Gokhale, Ph.D., RAC as Vice President, Global Head of Regulatory Affairs. In this role, Dr. Gokhale will be responsible for developing and implementing a comprehensive clinical regulatory strategy...
Read More
U.S. Food and Drug Administration announced important new steps to modernize breast cancer screening and help empower patients with more information when they are considering important decisions regarding their breast health care. For the first time in more than 20...
Read More
Accuprec Research Labs Pvt. Ltd. © 2025
